Eisai and fellow Japanese firm Nichi-Iko Pharmaceutical have agreed terms for a strategic capital and business alliance in the generics sector. 28 March 2018
Indian drugmakers Aurobindo, Zydus Cadila, Torrent Pharmaceuticals and Intas Pharmaceuticals are among suitors vying for the Sanofi’s (Euronext: SAN) attention, 12 January 2018
Indian generic drugmaker Alembic Pharmaceuticals has completed a buy of a New-Jersey based company that takes its number of abbreviated new drug application (AN 1 November 2017
The Cabinet Committee on Economic Affairs of India (CCEA) has decided to block Shanghai Fosun Pharmaceutical’s 8.5 billion yuan ($1.3 billion) takeover of the I 3 August 2017